# Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Caesarean Section

> **NCT06254131** · NA · COMPLETED · sponsor: **Tanta University** · enrollment: 75 (actual)

## Conditions studied

- Ondansetron Lozenge
- Postoperative Nausea and Vomiting
- Caesarean Section

## Interventions

- **DRUG:** Ondansetron lozenge (Ondalenz ©)
- **DRUG:** Ondansetron IV

## Key facts

- **NCT ID:** NCT06254131
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-10
- **Primary completion:** 2024-10-05
- **Final completion:** 2024-10-05
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2024-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06254131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06254131, "Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Caesarean Section". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06254131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*